CELLAI, LUCREZIA
 Distribuzione geografica
Continente #
NA - Nord America 894
EU - Europa 690
AS - Asia 170
AF - Africa 3
SA - Sud America 2
Totale 1.759
Nazione #
US - Stati Uniti d'America 886
RU - Federazione Russa 234
PL - Polonia 184
IT - Italia 80
IE - Irlanda 60
SG - Singapore 52
CN - Cina 50
HK - Hong Kong 38
SE - Svezia 35
GB - Regno Unito 20
FI - Finlandia 15
JO - Giordania 14
DE - Germania 13
FR - Francia 10
AT - Austria 9
IN - India 9
BE - Belgio 8
CA - Canada 7
CH - Svizzera 7
UA - Ucraina 6
PT - Portogallo 4
VN - Vietnam 4
CI - Costa d'Avorio 3
ES - Italia 3
BR - Brasile 2
NL - Olanda 2
TR - Turchia 2
JM - Giamaica 1
TW - Taiwan 1
Totale 1.759
Città #
Santa Clara 190
Warsaw 184
Fairfield 96
Chandler 66
Ashburn 60
Dublin 60
Woodbridge 52
Wilmington 42
Ann Arbor 38
Cambridge 38
Houston 38
Singapore 34
Altamura 24
Hong Kong 24
Lawrence 24
Princeton 24
Seattle 23
Florence 22
Beijing 21
Boston 13
Bremen 10
Moscow 10
Vienna 9
Boardman 8
Brussels 8
Buffalo 8
Bern 7
Mumbai 7
San Diego 7
Toronto 7
Shanghai 6
Kent 5
Dong Ket 4
Falls Church 4
Medford 4
Abidjan 3
Barcelona 3
Jacksonville 3
Rome 3
Ancona 2
Aprilia 2
Livorno 2
Nanjing 2
New York 2
Phoenix 2
Redwood City 2
Scandicci 2
Yubileyny 2
Anaheim 1
Bloomfield 1
Camerino 1
Castellammare di Stabia 1
Goiânia 1
Hangzhou 1
Helsinki 1
Lille 1
Limeira 1
London 1
Los Angeles 1
Milan 1
Napoli 1
Norwalk 1
Prescot 1
Taipei 1
Tappahannock 1
Wuhu 1
Wuxi 1
Xuzhou 1
Totale 1.227
Nome #
Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia. 270
Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia. 175
Role of adenosine in oligodendrocyte precursor maturation 168
Adenosine is present in rat brain synaptic vesicles. 148
Equilibrative Nucleoside Transporter ENT1 as a Biomarker of Huntington Disease 137
UDP-glucose enhances outward K+currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors 129
Low doses of the selective adenosine A2A receptor agonist CGS21680 are protective in a rat model of transient cerebral ischemia 95
Adenosine A2A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte culture 93
Role of adenosine A2A receptors in cerebral ischemia 90
Effect of chronic administration of selective adenosine A2A receptor agonists and antagonists on cerebral injury evaluated up to seven days after focal ischemia in the rat 78
Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: An overview 78
Adenosine as a biomarker of Huntington Disease 77
The selective A(2A) adenosine receptors stimulation reduces delayed rectifier potassium currents (I-K) and differentiation of cultured oligodendrocytes 76
Morquio B disease: From pathophysiology towards diagnosis 75
Time-course of the protective effect of selective adenosine A2A receptor agonists and antagonists after brain focal ischemia in the rat 71
Selective adenosine A2A receptor agonists and antagonists protect at different times after brain focal ischemia in the rat 58
Totale 1.818
Categoria #
all - tutte 5.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020176 0 0 0 0 28 28 20 28 22 25 24 1
2020/2021162 15 11 6 17 16 11 12 14 17 23 12 8
2021/2022107 9 12 2 5 5 4 7 7 4 4 15 33
2022/2023341 38 60 25 16 28 57 44 11 47 2 4 9
2023/2024101 6 15 16 2 6 7 5 29 1 4 8 2
2024/2025552 31 94 58 127 242 0 0 0 0 0 0 0
Totale 1.818